Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): Second interim analysis of the Global Investigation of Therapeutic Decisions in HCC and of Its Treatment with Sorafenib (GIDEON) study.
Jeff H. Geschwind
Consultant or Advisory Role - Bayer; Biocompatibles; BioSphere Medical; Guerbet
Research Funding - Bayer; Biocompatibles; BioSphere Medical; ContextVision; Genentech; Gideon; MDS Nordion; Philips Medical; RSNA
Riccardo Lencioni
Honoraria - Bayer
Jorge A. Marrero
Honoraria - Bayer; Onyx
Research Funding - Bayer
Alan Paul Venook
Consultant or Advisory Role - Abbott Laboratories (U); Bristol-Myers Squibb (U); Chugai Pharma (U)
Research Funding - Bayer; Onyx
Sheng-Long Ye
No relevant relationships to disclose
Keiko Nakajima
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Frank Cihon
Employment or Leadership Position - Bayer
Masatoshi Kudo
No relevant relationships to disclose